Home / Brands / Amerisource Health Services

Amerisource Health Services Recalls

69 recalls on record · January 20, 2016 to May 27, 2026 · Drugs

Recalls by year

Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.

July 17, 2024DrugsFDA

Amerisource Health Services LLC recalls buPROPion Hydrochloride Extended-release Tablets USP (XL) Once-Daily, 150 mg, 100 Tablets (10 x 10) per carton, Rx Only,

Hazard: Failed Dissolution Specifications; the product is dissolving faster than the specified limits.

February 14, 2024DrugsFDA

Amerisource Health Services LLC recalls HydrALAZINE Hydrochloride Tablets, USP, 10 mg, 100-count (10 x 10) per unit dose carton, Rx Only, Distributed by: Americ

Hazard: Failed Impurities/Degradation Specifications: Out of Specification (OOS) result in the repackaged product for Related Compounds (Impurities) at the 6-month time point.

February 14, 2024DrugsFDA

Amerisource Health Services LLC recalls Febuxostat Tablets, 40 mg, 30 Tablets (3 x 10) per carton, Rx only, Distributed by: American Health Packaging, Columbus,

Hazard: CGMP Deviations

February 7, 2024DrugsFDA

Amerisource Health Services LLC recalls Rifampin Capsules USP, 150 mg, 30 Capsules (3 x 10) unit doses per carton, Rx Only, Distributed by: American Health Pack

Hazard: Failed Impurities/Degradation Specification.

January 31, 2024DrugsFDA

Amerisource Health Services LLC recalls Benzonatate Capsules, USP, 100 mg, 100 Capsules (10 capsules x 10 unit dose cards), Rx only, Distributed by: American He

Hazard: Superpotent drug: Assay results were slightly above specification at the time zero point.

October 11, 2023DrugsFDA

Amerisource Health Services LLC recalls HydrALAZINE Hydrochloride Tablets, USP, 10 mg, 100 Tablets (10 x 10) per carton, Rx Only, Distributed by: American Healt

Hazard: Failed Impurities/Degradation Specifications: Out of Specification results in the repackaged product for impurities at the 12-month time point.

July 12, 2023DrugsFDA

Amerisource Health Services LLC recalls Tizanidine Tablets, USP, 4 mg, 100 Tablets (10 tablets x 10 unit dose blister packs) per carton, Rx Only, Packaged and D

Hazard: Failed Dissolution Specifications: this repackaged product was recalled by the manufacturer, Dr. Reddy's Laboratories, Inc., due to out of specification results for dissolution.

May 31, 2023DrugsFDA

Amerisource Health Services LLC recalls Glimepiride Tablets, USP, 4 mg, RX, Packaged as a) 100-count bottle, NDC# 68001-179-00; b) 500-count bottle, NDC# 68001-

Hazard: CGMP Deviations: recalling drug products following an FDA inspection.

May 31, 2023DrugsFDA

Amerisource Health Services LLC recalls Glimepiride Tablets, USP, 2 mg, RX, Packaged as a ) 100-count bottle, NDC# 68001-178-00; b) 500-count bottle; NDC# 6800

Hazard: CGMP Deviations: recalling drug products following an FDA inspection.

May 31, 2023DrugsFDA

Amerisource Health Services LLC recalls Glimepiride Tablets, USP, 1 mg, RX, Packaged as a)100-count bottle, NDC# 68001-177-00; b) 500-count bottle, NDC# 68001-1

Hazard: CGMP Deviations: recalling drug products following an FDA inspection.

April 26, 2023DrugsFDA

Amerisource Health Services LLC recalls Verapamil Hydrochloride Extended-Release Tablets, USP, 180 mg, 100 Tablets (10 x 10) per carton, Rx only, Distributed by

Hazard: Failed Dissolution Specifications: Out of specification dissolution results above specified values.

March 15, 2023DrugsFDA

Amerisource Health Services LLC recalls Verapamil Hydrochloride Extended-Release Tablets, USP, 120 mg, Rx Only, 100 Tablets per Carton (10 x 10), Distributed by

Hazard: Failed Dissolution Specification: Out of specification dissolution results at time point zero. The OOS was above specified values.

February 22, 2023DrugsFDA

Amerisource Health Services LLC recalls BuPROPion Hydrochloride Tablets, USP 75 mg, 100 Tablets (10 x 10) per carton, Rx Only, Distributed by: American Health P

Hazard: Failed Impurities/Degradation Specifications

February 22, 2023DrugsFDA

Amerisource Health Services LLC recalls Metoprolol Succinate Extended-Release Tablets, USP, 50 mg, packaged in (a) 100-count bottle, NDC 68001-501-00; (b) 500-c

Hazard: Failed Dissolution Specifications: This recall is being initiated in support of the recall by the manufacturer which included lots that were packaged for BluePoint Laboratories.

January 25, 2023DrugsFDA

Amerisource Health Services LLC recalls Rifampin Capsules USP, 300 mg, 100 Capsules (10 x 10) per carton, Rx Only, Distributed by: American Health Packaging, Co

Hazard: Failed Impurities/Degradations Specifications

August 24, 2022DrugsFDA

Amerisource Health Services LLC recalls Azacitidine for Injection, 100 mg Lyophilized Powder, Single-Dose Vials, Rx Only, Manufactured by: Intas Pharmaceutical

Hazard: Subpotent Drug

November 29, 2017DrugsFDA

Amerisource Health Services recalls Paroxetine Tablets, USP, 30mg, 100 tablets (10 x 10) , Rx Only, Distributed by: American Health Packaging, Columbus, Ohi

Hazard: Presence of Foreign Tablets/Capsules.

November 22, 2017DrugsFDA

Amerisource Health Services recalls Enalapril Maleate Tablets, USP, 5 mg, 100 Tablets (10 x 10), Rx Only. Packaged and Distributed by: American Health Pac

Hazard: Failed Stability Specifications

March 22, 2017DrugsFDA

Amerisource Health Services recalls GlipiZIDE Extended-release tablets, 2.5 mg, 30-count carton (NDC 68084-295-21), Individual dose (NDC 68084-395-11), Rx O

Hazard: Failed dissolution specifications: Glipizide 2.5 mg ER Tablets exceeded dissolution specification rates for the 10 hour testing point.

March 8, 2017DrugsFDA

Amerisource Health Services recalls CycloSPORINE Capsules, USP, 100 mg, 30 count (5x6) blister cartons, Rx only, Distributed by American Health Packaging, C

Hazard: Failed Impurities/Degradations Specifications; out of specification results for Maximum Unknown Impurities and Total Impurities

November 30, 2016DrugsFDA

Amerisource Health Services recalls AHP NIFEdipine Capsules, 10mg USP, 100 count carton (NDC: 68084-022-01); Individual Blister (NDC: 68084-022-11), Rx Only

Hazard: Presence of Foreign Tablets/Capsules

November 23, 2016DrugsFDA

Amerisource Health Services recalls Bupropion Hydrochloride Extended-Release Tablets, USP (XL), 300 mg, a) 90-count bottle (NDC 68001-264-05), b) 500-coun

Hazard: Failed Dissolution Specifications: The firm was notified that there was a dissolution out of specification result on the 6 month stability samples.

October 19, 2016DrugsFDA

Amerisource Health Services recalls Paricalcitol Capsules, 1 mcg, packaged in 30 Capsules (5 x 6) per carton (NDC 60687-106-25); each blister card containin

Hazard: Failed Impurities/Degradation Specifications: This repackaged product was recalled by its manufacturer due to failed results for impurities.

September 21, 2016DrugsFDA

Amerisource Health Services recalls buPROPion Hydrochloride Extended-Release Tablets, USP (XL), 300mg, 500-count bottle, Rx only, Manufactured by: Cadila He

Hazard: Failed dissolution specifications - the out of specification result for dissolution was identified during 3 month stability testing.

September 14, 2016DrugsFDA

Amerisource Health Services recalls Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate (Mix

Hazard: Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule

September 14, 2016DrugsFDA

Amerisource Health Services recalls Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate (Mix

Hazard: Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule

September 14, 2016DrugsFDA

Amerisource Health Services recalls Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate (Mix

Hazard: Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule

September 14, 2016DrugsFDA

Amerisource Health Services recalls Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate (Mix

Hazard: Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule

September 14, 2016DrugsFDA

Amerisource Health Services recalls Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate (Mix

Hazard: Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule

September 14, 2016DrugsFDA

Amerisource Health Services recalls Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Tabl

Hazard: Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule